BRUTON TYROSINE KINASE INHIBITOR

Clinical trials for BRUTON TYROSINE KINASE INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new BRUTON TYROSINE KINASE INHIBITOR trials appear

Sign up with your email to follow new studies for BRUTON TYROSINE KINASE INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Researchers map the uncertain path after leukemia drugs fail

Knowledge-focused Completed

This study looked back at the medical records of 152 adults with chronic lymphocytic leukemia (CLL) to understand what happens after two common types of oral medications stop working. The goal was to see what treatments doctors tried next and how patients responded, because there…

Matched conditions: BRUTON TYROSINE KINASE INHIBITOR

Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused

Last updated Apr 01, 2026 14:43 UTC

BRUTON TYROSINE KINASE INHIBITOR

Get alerted when new BRUTON TYROSINE KINASE INHIBITOR trials appear

Researchers map the uncertain path after leukemia drugs fail